Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

July 1, 2020
Preprint
Open Access

Functional impact and regulation of global alternative splicing patterns in heart development and disease

BioRxiv : the Preprint Server for Biology
C. Marti-GomezEnrique Lara-Pezzi
July 4, 2020
Preprint

BRG1 promotes transcriptional patterns that are permissive to proliferation in cancer cells

BioRxiv : the Preprint Server for Biology
K. A. GilesPhillippa C Taberlay
July 4, 2020

A role for alternative splicing in circadian control of exocytosis and glucose homeostasis

Genes & Development
Biliana MarchevaJoseph Bass
July 4, 2020
Preprint

Comparative poly(A)+ RNA interactome capture of fission yeast RNA exosome mutants reveals insights into RNA biogenesis

BioRxiv : the Preprint Server for Biology
A. BirotLidia Vasilieva
July 1, 2020

Identification of Prognostic Signatures of Alternative Splicing in Glioma

Journal of Molecular Neuroscience : MN
Yu ZengYe Song
July 4, 2020
Preprint

Cardiomyocyte-specific Srsf3 deletion reveals a mitochondrial regulatory role

BioRxiv : the Preprint Server for Biology
A.-A. DumontMannix Auger-Messier
July 4, 2020
Preprint

New GFAP splice isoform (GFAPμ) differentially expressed in glioma translates into 21 kDa N-terminal GFAP protein

BioRxiv : the Preprint Server for Biology
E. van BodegravenElly M. Hol
July 3, 2020
Review

Poison exons in neurodevelopment and disease

Current Opinion in Genetics & Development
Gemma L Carvill, Heather C Mefford
July 1, 2020

Coverage-dependent bias creates the appearance of binary splicing in single cells

ELife
Carlos F Buen Abad NajarLiana F Lareau
July 2, 2020
Open Access

SnoRNA signatures in cartilage ageing and osteoarthritis

Scientific Reports
Mandy J PeffersTim J M Welting
July 6, 2020
Review

Cav1.2 channelopathies causing autism: new hallmarks on Timothy syndrome

Pflügers Archiv : European journal of physiology
Andrea MarcantoniEmilio Carbone
July 1, 2020
Review
Open Access

The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer

Frontiers in Cell and Developmental Biology
Andrea CerasuoloMaria Lina Tornesello
July 7, 2020

Understanding and therapeutic targeting of aberrant mRNA splicing mechanisms in oncogenesis

[Rinshō ketsueki] The Japanese journal of clinical hematology
Atsushi TanakaDaichi Inoue

Sign up to follow this feed and discover related papers.

Related Feeds

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR Screens in Virology

This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that affect virus-host interactions. Here is the latest research.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

© 2020 Meta ULC. All rights reserved
/feed-previews/alternative-splicing/74162fec-4777-4430-b61a-12f563c8cd7c